Substance use, psychiatric symptoms and the onset of schizophrenic illness

References

• Achenbach T. M. Integrative guide for the 1991 CBCL/4‐18 YSR, and TRF proviles. University of Vermont Department of Psychiatry, Burlington, VTG 1991
   Google Scholar
• Andréasson S., Allebeck P., Engstrom A., Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987; 2((8574))1483–1486
   Google Scholar
• Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. E. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 2002; 325((7374))1212–1213
   Google Scholar
• Arseneault L., Cannon M., Witton J., Murray R. M. Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 2004; 184: 110–117
   PubMed Web of Science ®Google Scholar
• Baum K. M., Walker E. F. Childhood behavioral precursors of adult symptom dimensions in schizophrenia. Schizophrenia Research 1995; 16((2))111–120
   Google Scholar
• Beck K. H., Thombs D. L., Mahoney C. A., Fingar K. M. Social context and sensation seeking: gender differences in college student drinking motivations. International Journal of Addiction 1995; 30((9))1101–1115
   Google Scholar
• Cantwell R., Harrison G. Substance misuse in the severely mentally ill. Advances in Psychiatric Treatment 1996; 2: 117–124
   Google Scholar
• Castle D. J., Ames F. R. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996; 30((2))179–183
   Google Scholar
• Johns A. Psychiatric effects of cannabis. British Journal of Psychiatry 2001; 178: 116–122
   PubMed Web of Science ®Google Scholar
• Johnstone E. C., Abukmeil S. S., Byrne M., Clafferty R., Grant E., Hodges A., et al. Edinburgh high risk study — Findings after four years. Demographic, attainment and psychopathological issues. Schizophrenia Research 2000; 46: 1–15
   PubMedGoogle Scholar
• Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994; 344((8934))1398–1402
   Google Scholar
• McGorry P. D., McFarlane C., Patton G. C., Bell R., Hibbert M. E., Jackson H. J., et al. The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica 1995; 92((4))241–249
   Google Scholar
• McKay D. R., Tennant C. C. Is the grass greener? The link between cannabis and psychosis. Medical Journal of Australia 2000; 172((6))284–286
   Google Scholar
• Miller P., Lawrie S. M., Hodges A., Clafferty R., Cosway R., Johnstone E. C. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2001; 36: 338–342
   PubMed Web of Science ®Google Scholar
• Miller P., Plant M. Heavy cannabis use among UK teenagers: an exploration. Drug and Alcohol Dependence 2002a; 65((3))235–242
   PubMed Web of Science ®Google Scholar
• Miller P. M., Byrne M., Hodges A., Lawrie S. M., Johnstone E. C. Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the Edinburgh high risk study. Psychological Medicine 2002b; 32((1))173–179
   Google Scholar
• Miller P. M., Plant M. Drinking, smoking, and illicit drug use among 15 and 16 year olds in the United Kingdom. British Medical Journal 1996; 313((7054))394–397
   PubMed Web of Science ®Google Scholar
• Novacek J., Raskin R., Hogan R. Why do adolescents use drugs? Age, sex and user differences. Journal of Youth and Adolescence 1991; 20: 475–492
   PubMed Web of Science ®Google Scholar
• Owens D. G. C., Miller P. M., Lawrie S. M., Johnstone E. C. Pathogenesis of schizophrenia — a psychopathological perspective. British Journal of Psychiatry 2005; 186: 386–393
   PubMed Web of Science ®Google Scholar
• Phillips L. J., Curry C., Yung A. R., Yuen H. P., Adlard S., McGorry P. D. Cannabis use is not associated with the development of psychosis in an 'ultra' high‐risk group. Australian and New Zealand Journal of Psychiatry 2002; 36((6))800–806
   Google Scholar
• Plant M., Miller P. Drug use has declined among teenagers in United Kingdom. British Medical Journal 2000; 320((7248))1536–1537
   Google Scholar
• Plant M. A., Miller P. M. Alcohol and drug use in UK teenagers 1995–2003. Journal of Substance Use, (Submitted) 2004
   Google Scholar
• Rossi A., Pollice R., Daneluzzo E., Marinangeli M. G., Stratta P. Behavioral neurodevelopment abnormalities and schizophrenic disorder: a retrospective evaluation with the Childhood Behavior Checklist (CBCL). Schizophrenia Research 2000; 44((2))121–8
   Google Scholar
• Sembhi S., Lee J. W. Cannabis use in psychotic patients. Austalian and New Zealand Journal of Psychiatry 1999; 33((4))529–32
   Google Scholar
• Tennant C. C., Rey J. Psychiatric illness in young people using cannabis: evidence update. Medicine Today 2003; 4: 72–74
   Google Scholar
• van Os J., Bak M., Hanssen M., Bijl R. V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population‐based study. American Journal of Epidemiology 2002; 156((4))319–327
   PubMed Web of Science ®Google Scholar
• Verdoux H., Gindre C., Sorbara F., Tournier M., Swendsen J. D. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 2003; 33((1))23–32
   Google Scholar
• Wing J. K., Cooper J. E., Sartorius N. The Description and Classification of Psychiatric Symptoms. An Instruction Manual for the PSE and Catego Systems. Cambridge University Press, Cambridge 1974
   Google Scholar